{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:31:32Z","timestamp":1785148292973,"version":"3.55.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,19]]},"DOI":"10.7759\/cureus.84407","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:20:47Z","timestamp":1747668047000},"source":"Crossref","is-referenced-by-count":2,"title":["Evolving Magnetic Resonance Imaging (MRI) Findings in Immune Effector Cell-Associated Neurotoxicity Syndrome"],"prefix":"10.7759","author":[{"given":"Mark D","family":"Marino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kardasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamseldeen Y","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee DW","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL, et al.. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019, 25:625-38. 10.1016\/j.bbmt.2018.12.758","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.879608","article-title":"Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy","volume":"13","author":"Sterner RC","year":"2022","unstructured":"Sterner RC, Sterner RM. Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy. Front Immunol. 2022, 13:879608. 10.3389\/fimmu.2022.879608","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.577027","article-title":"Cytokines in CAR T cell-associated neurotoxicity","volume":"11","author":"Gust J","year":"2020","unstructured":"Gust J, Ponce R, Liles WC, Garden GA, Turtle CJ. Cytokines in CAR T cell-associated neurotoxicity. Front Immunol. 2020, 11:577027. 10.3389\/fimmu.2020.577027","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2074990","article-title":"Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy","volume":"63","author":"Lapidus AH","year":"2022","unstructured":"Lapidus AH, Anderson MA, Harrison SJ, Dickinson M, Kalincik T, Lasocki A. Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy. Leuk Lymphoma. 2022, 63:2364-74. 10.1080\/10428194.2022.2074990","journal-title":"Leuk Lymphoma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa183","article-title":"Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes","volume":"23","author":"Holtzman NG","year":"2021","unstructured":"Holtzman NG, Xie H, Bentzen S, et al.. Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes. Neuro Oncol. 2021, 23:112-21. 10.1093\/neuonc\/noaa183","journal-title":"Neuro Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6042","article-title":"Chimeric antigen receptor T-cell therapy: what the neuroradiologist needs to know","volume":"40","author":"Valand HA","year":"2019","unstructured":"Valand HA, Huda F, Tu RK. Chimeric antigen receptor T-cell therapy: what the neuroradiologist needs to know. AJNR Am J Neuroradiol. 2019, 40:766-8. 10.3174\/ajnr.A6042","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1148\/rg.210065","article-title":"Imaging primer on chimeric antigen receptor T-cell therapy for radiologists","volume":"42","author":"de Groot PM","year":"2022","unstructured":"de Groot PM, Arevalo O, Shah K, et al.. Imaging primer on chimeric antigen receptor T-cell therapy for radiologists. Radiographics. 2022, 42:176-94. 10.1148\/rg.210065","journal-title":"Radiographics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369163-evolving-magnetic-resonance-imaging-mri-findings-in-immune-effector-cell-associated-neurotoxicity-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:20:48Z","timestamp":1747668048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369163-evolving-magnetic-resonance-imaging-mri-findings-in-immune-effector-cell-associated-neurotoxicity-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.84407","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,19]]}}}